Schizophrenia Bulletin

Journal

Publication Venue For

  • White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Na├»ve First-Episode Psychosis Patients.  47:1068-1076. 2021
  • Assessing Reality Testing in Mice through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.  46:54-67. 2020
  • Reduced neural sensitivity to social vs nonsocial reward in schizophrenia.  45:620-628. 2019
  • 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.  45:180-189. 2019
  • Extracellular Vesicles for Research on Psychiatric Disorders..  45:7-16. 2019
  • Schizophrenia-like dopamine release abnormalities in a mouse model of NMDA receptor hypofunction.  45:138-147. 2019
  • Social cognitive skills training for psychosis with community-based training exercises: A randomized controlled trial.  44:1254-1266. 2018
  • Episodic Memory for Dynamic Social Interaction Across Phase of Illness in Schizophrenia.  44:620-630. 2018
  • Social Disconnection in Schizophrenia and the General Community.  44:242-249. 2018
  • Thought disorder in schizophrenia and bipolar disorder probands, their relatives, and nonpsychiatric controls.  43:523-535. 2017
  • Testing the validity of taxonic schizotypy using genetic and environmental risk variables.  43:633-643. 2017
  • Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional mri study.  42:1046-1055. 2016
  • Cortical PGC-1?-dependent transcripts are reduced in postmortem tissue from patients with schizophrenia.  42:1009-1017. 2016
  • The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia.  40:1308-1318. 2014
  • Adapting social neuroscience measures for schizophrenia clinical trials, part 1: Ferrying paradigms across perilous waters.  39:1192-1200. 2013
  • Adapting social neuroscience measures for schizophrenia clinical trials, part 2: Trolling the depths of psychometric properties.  39:1201-1210. 2013
  • Adapting social neuroscience measures for schizophrenia clinical trials, part 3: Fathoming external validity.  39:1211-1218. 2013
  • An intact social cognitive process in schizophrenia: Situational context effects on perception of facial affect.  39:640-647. 2013
  • Neural substrates of empathic accuracy in people with schizophrenia.  39:617-628. 2013
  • Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: A meta-analysis.  39:102-111. 2013
  • Social cognition in schizophrenia, part 1: Performance across phase of illness.  38:854-864. 2012
  • Social cognition in schizophrenia, part 2: 12-month stability and prediction of functional outcome in first-episode patients.  38:865-872. 2012
  • How do schizophrenia patients use visual information to decode facial emotion?.  37:1001-1008. 2011
  • Visual masking in schizophrenia: Overview and theoretical implications.  37:700-708. 2011
  • Using event related potentials to explore stages of facial affect recognition deficits in schizophrenia.  34:679-687. 2008
  • Decreased expression of tyrosine hydroxylase in the substantia nigra of schizophrenia brains.  33:266-266. 2007
  • The expression of presynaptic dopamine neuronal markers in postmortem tissue of schizophrenic substantia nigra.  33:260-260. 2007
  • Financial capacity in persons with schizophrenia and serious mental illness: Clinical and research ethics aspects.  32:81-91. 2006
  • International Standard Serial Number (issn)

  • 0586-7614
  • Electronic International Standard Serial Number (eissn)

  • 1745-1701